Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Lisdexamfetamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,809Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6TARO PHARMACEUTICALS INC

    02 6SANDOZ CANADA INCORPORATED

    03 13TAKEDA CANADA INC

    04 7TEVA CANADA LIMITED

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 10MG

    Packaging :

    Approval Date :

    Application Number : 2533340

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 20MG

    Packaging :

    Approval Date :

    Application Number : 2533359

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 30MG

    Packaging :

    Approval Date :

    Application Number : 2533367

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 40MG

    Packaging :

    Approval Date :

    Application Number : 2533375

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number : 2533383

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 60MG

    Packaging :

    Approval Date :

    Application Number : 2533391

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    TAKEDA CANADA INC

    Japan
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 50MG

    Packaging : 100

    Approval Date :

    Application Number : 2322978

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    TAKEDA CANADA INC

    Japan
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 30MG

    Packaging : 100

    Approval Date :

    Application Number : 2322951

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TAKEDA CANADA INC

    Japan
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 70MG

    Packaging : 100

    Approval Date :

    Application Number : 2458071

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    TAKEDA CANADA INC

    Japan
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 10MG

    Packaging :

    Approval Date :

    Application Number : 2490226

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF